Open Interest and Volume Dynamics
The latest data shows Apollo Hospitals’ open interest (OI) in derivatives rising sharply to 58,052 contracts, up 11.74% from the previous 51,955. This increase of 6,097 contracts is significant, indicating fresh positions being established or existing ones being rolled over. Concurrently, the volume stood at 40,713 contracts, reflecting robust trading activity in the derivatives market.
In terms of value, futures contracts accounted for ₹78,340.48 lakhs, while options contracts represented a staggering ₹27,793.94 crores, culminating in a total derivatives value of approximately ₹79,780.90 lakhs. This substantial derivatives turnover underscores the stock’s liquidity and attractiveness among traders seeking to capitalise on volatility or hedge existing exposures.
Price Performance and Market Context
On the cash market front, Apollo Hospitals’ share price closed at ₹6,798, marginally down by 0.45% on the day, underperforming the Sensex which gained 0.22%. The stock outperformed its hospital sector peers by 0.26%, however, signalling relative resilience amid sector-wide pressures. Notably, the stock has reversed its five-day consecutive decline, hinting at a potential short-term recovery.
Despite this, the share price remains below all major moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – indicating a prevailing bearish trend. This technical backdrop suggests that while short-term buying interest has emerged, the broader trend remains subdued, warranting cautious optimism among investors.
Investor Participation and Liquidity
Investor participation has notably increased, with delivery volumes rising to 3.77 lakh shares on 21 January, a 36.71% jump compared to the five-day average. This surge in delivery volume reflects stronger conviction among buyers willing to hold shares beyond intraday trading, a positive sign for the stock’s underlying demand.
Liquidity remains adequate, with the stock capable of supporting trade sizes up to ₹6.84 crores based on 2% of the five-day average traded value. This level of liquidity is favourable for institutional investors and traders seeking to execute sizeable orders without significant market impact.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Interpreting the Open Interest Surge
The 11.74% increase in open interest, coupled with strong volume, suggests that market participants are actively repositioning in Apollo Hospitals derivatives. Such a rise often indicates fresh capital inflows and can precede significant price moves. However, the mixed signals from price action and technical indicators imply that the market is currently indecisive on the stock’s near-term direction.
Given the stock’s recent trend reversal after a prolonged decline, some traders may be initiating bullish bets, anticipating a recovery. Conversely, the fact that the stock trades below all key moving averages may encourage cautious or bearish positioning among others, possibly reflected in put option activity or short futures positions.
Market participants should also consider the broader hospital sector dynamics and macroeconomic factors influencing healthcare demand and regulatory environment, which can impact investor sentiment and derivative positioning.
Mojo Score and Analyst Ratings
Apollo Hospitals currently holds a Mojo Score of 50.0, categorised as a Hold rating. This represents a downgrade from a previous Buy rating as of 9 January 2026, reflecting a more cautious stance by analysts. The market cap grade stands at 1, indicating the company’s large-cap status with a market capitalisation of ₹99,156 crores.
The downgrade aligns with the stock’s technical weakness and the mixed signals from derivatives activity, suggesting investors should monitor developments closely before committing to fresh positions.
Sector and Benchmark Comparison
While Apollo Hospitals marginally outperformed its hospital sector peers on the day, the sector itself lagged behind the broader Sensex index. This relative outperformance may attract selective interest from investors seeking defensive or growth-oriented healthcare stocks amid market volatility.
However, the stock’s underperformance relative to the Sensex and its technical challenges highlight the need for a balanced approach, weighing both fundamental strengths and near-term risks.
Holding Apollo Hospitals Enterprise Ltd. from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Outlook and Investor Considerations
Investors analysing Apollo Hospitals should consider the implications of the open interest surge in conjunction with price trends and sector fundamentals. The derivatives market activity points to increased speculative interest, which could translate into heightened volatility in the near term.
Given the Hold rating and recent downgrade, a cautious approach is advisable. Investors may look for confirmation of trend reversal through sustained price gains above key moving averages and improved sector momentum before increasing exposure.
Additionally, monitoring delivery volumes and liquidity metrics can provide insights into genuine investor participation versus short-term trading activity.
Conclusion
The sharp rise in open interest for Apollo Hospitals Enterprise Ltd. highlights a dynamic derivatives market with active repositioning. While the stock shows signs of a short-term rebound, its technical positioning and cautious analyst outlook suggest that investors should remain vigilant. Balancing the increased speculative activity with fundamental and technical analysis will be key to navigating the stock’s near-term trajectory.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
